The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2022

Filed:

Apr. 28, 2017
Applicants:

Universidad Autónoma DE Madrid, Madrid, ES;

Imdea Alimentacion, Madrid, ES;

Hospital Universitario Infanta Sofia, San Sebastián de los Reyes—Madrid, ES;

Inventors:

Carlos Torres Olivares, Madrid, ES;

Luis Vázquez De Frutos, Madrid, ES;

Marta Corzo, Madrid, ES;

Pablo Arranz, Madrid, ES;

Ana Ramírez De Molina, Madrid, ES;

Guillermo Reglero Rada, Madrid, ES;

Viviana Loria Kohen, Madrid, ES;

Marta Gómez De Cedrón, Madrid, ES;

Juan Moreno Rubio, Madrid, ES;

José Moisés Laparra Llopis, Madrid, ES;

Enrique Casado Sáenz, Madrid, ES;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/53 (2006.01); A23L 33/105 (2016.01); A61K 47/44 (2017.01); A61K 47/14 (2017.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 9/08 (2006.01); A61K 47/46 (2006.01); A23L 33/115 (2016.01); A61P 13/12 (2006.01); A61P 35/00 (2006.01); A61K 35/60 (2006.01);
U.S. Cl.
CPC ...
A23L 33/105 (2016.08); A23L 33/115 (2016.08); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 35/60 (2013.01); A61K 36/53 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/44 (2013.01); A61K 47/46 (2013.01); A61P 13/12 (2018.01); A61P 35/00 (2018.01);
Abstract

The present disclosure provides compositions comprising a supercritical rosemary extract and a lipid system comprising raffish liver oil or the product of an enzymatic or chemical glycerolysis processing of ratfish liver oil. The present disclosure also provides use of said compositions for immunotherapy potentiators or adjuvants for patients with cancer or immunological disorders; treatment of autoimmune-based immunological disorder selected from the group consisting of: rheumatoid arthritis, type I diabetes, psoriasis, celiac disease and multiple sclerosis; treatment of tumor growth, chronic lymphocytic choriomeningitis virus infection, hepatitis (B and C) virus infection, or human immunodeficiency virus infection; or prevention of kidney damage.


Find Patent Forward Citations

Loading…